It’s a story often repeated in South Africa’s neglected public healthcare system: old equipment, untrained staff, and a general lack of resources. In Gauteng, it’s a story that’s grown to reveal an unprecedented level of crisis. The province’s only two oncology radiation units are creaking under the strain of overwhelming demand and desperately ill patients are left waiting months, even years, for life-saving treatment. Carte Blanche investigates.
CELGENE FLAGGED
For overpricing bone marrow cancer drug The Competition Commission has referred for prosecution to the Competition Tribunal (“Tribunal”), international drug manufacturer Celgene Corporation (“Celgene Corp”) and its subsidiary Celgene Logistics S.a.r.l (“Celgene...